F.Javier Garcia-Fernandez

Prof. F.Javier Garcia-Fernandez

Burgos University Hospital, Burgos, Castille-Leon, Spain

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2004 in Circulation
Verified
Journal Article
Closed access
PDF file
AAAngel Arenal
Angel Arenal
SCSilvia del Castillo
Silvia del Castillo
EGEsteban Gonzalez-Torrecilla
Esteban Gonzalez-Torrecilla
FAFelipe Atienza
Felipe Atienza
MOMercedes Ortiz
Mercedes Ortiz
JAJesús Almendral
Jesús Almendral
Background— Endocardial mapping before sustained monomorphic ventricular tachycardia (SMVT) induction may reduce mapping time during tachycardia and facilitate the ablation of unmappable VT. Methods and Results— Left ventricular electroanatomic voltage maps obtained during right ventricular apex pacing in 26 patients with chronic myocardial infarction referred for VT ablation were analyzed to identify conducting channels (CCs) inside the scar tissue. A CC was defined by the presence of a corridor of consecutive electrograms differentiated by higher voltage amplitude than the surrounding area. The effect of different levels of voltage scar definition, from 0.5 to 0.1 mV, was analyzed. Twenty-three channels were identified in 20 patients. The majority of CCs were identified when the voltage scar definition was ≤0.2 mV. Electrograms with ≥2 components were recorded more frequently at the inner than at the entrance of CCs (100% versus 75%, P ≤0.01). The activation time of the latest component was longer at the inner than at the entrance of CCs (200±40 versus 164±53 ms, P ≤0.001). Pacing from these CCs gave rise to a long-stimulus QRS interval (110±49 ms). Radiofrequency lesion applied to CCs suppressed the inducibility in 88% of CC-related tachycardias. During a follow-up of 17±11 months, 23% of the patients experienced a VT recurrence. Conclusions— CCs represent areas of slow conduction that can be identified in 75% of patients with SMVT. A tiered decreasing-voltage definition of the scar is critical for CC identification.


21 February 2019 in European Heart Journal
Verified
Journal Article
Open access
FGF.Javier Garcia-Fernandez
F.Javier Garcia-Fernandez
JAJoaquín Osca Asensi
Joaquín Osca Asensi
RRRafael Romero
Rafael Romero
ILIgnacio Fernández Lozano
Ignacio Fernández Lozano
JLJosé María Larrazabal
José María Larrazabal
MKMehrard Moradi Kolbolandi
Mehrard Moradi Kolbolandi
Aims: This trial aimed to evaluate the safety and efficiency of a common and simplified protocol for the surveillance of cardiac implantable electronic devices based on remote monitoring (RM) in patients with pacemakers (PMs) and implantable cardiac defibrillators (ICDs) for at least 24 months. Methods and results: The RM-ALONE is a multicentre prospective trial that randomly assigned 445 patients in two groups, both followed by RM: the home monitoring-only (HMo) based on RM + remote interrogations (RIs) every 6 months and the HM + IO that adds in-office evaluations every 6 months to RM. Four hundred and forty-five patients were enrolled in the study, 294 PMs and 151 ICDs recipients. In the HMo group, 20% of patients experienced ≥1 major adverse cardiac event (MACE) vs. 19.5% in HM + IO group (P = 0.006 for non-inferiority). The proportion of patients with a PM/ICD who experienced ≥1 MACE was 15.2/29.3% in HMo group and 16.1/26.3% in HM + IO group (hazard ratio 0.95/1.15, 95% confidence interval 0.53–1.70/0.62–2.10). There were 789 in-office evaluations (136 in the HMo and 653 in the HM + IO; P < 0.001). There was a 79.2% reduction of in-office evaluations with no significant differences in unscheduled visits between groups: 122 (54.5%) in HMo and 101 (45.3%) in HM + IO; P = 0.15. The time a physician/nurse spent per patient/follow-up was significantly reduced in the HMo group: 4/5 min (0–30)/(1–30) vs. 10/10 min (0–40)/(1–40) in HM + IO (P < 0.0001). Conclusion: The RM-ALONE protocol common for ICD and PM surveillance, consisting of RM + RI every 6 months has proven safe and efficient in reducing hospital visits and staff workload.

1 October 2015 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Open access
PDF file
DCDavid Calvo
David Calvo
FAFelipe Atienza
Felipe Atienza
JSJavier Saiz
Javier Saiz
LMLaura Martinez-Mateu
Laura Martinez-Mateu
PÁPablo Ávila
Pablo Ávila
OBOmer Berenfeld
Omer Berenfeld
Background— Ventricular fibrillation (VF) has been proposed to be maintained by localized high-frequency sources. We tested whether spectral-phase analysis of the precordial ECG enabled identification of periodic activation patterns generated by such sources. Methods and Results— Precordial ECGs were recorded from 15 ischemic cardiomyopathy and 15 Brugada syndrome (type 1 ECG) patients during induced VF and analyzed in the frequency-phase domain. Despite temporal variability, induced VF episodes lasting 19.6±7.9 s displayed distinctly high power at a common frequency (shared frequency, 5.7±1.1 Hz) in all leads about half of the time. In patients with Brugada syndrome, phase analysis of shared frequency showed a V1–V6 sequence as would be expected from patients displaying a type 1 ECG pattern (P<0.001). Hilbert-based phases confirmed that the most stable sequence over the whole VF duration was V1–V6. Analysis of shared frequency in ischemic cardiomyopathy patients with anteroseptal (n=4), apical (n=3), and inferolateral (n=4) myocardial infarction displayed a sequence starting at V1–V2, V3–V4, and V5–V6, respectively, consistent with an activation origin at the scar location (P=0.005). Sequences correlated with the Hilbert-based phase analysis (P<0.001). Posterior infarction (n=4) displayed no specific sequence. On paired comparison, phase sequences during monomorphic ventricular tachycardia correlated moderately with VF (P<0.001). Moreover, there was a dominant frequency gradient from precordial leads facing the scar region to the contralateral leads (5.8±0.8 versus 5.4±1.1 Hz; P=0.004). Conclusions— Noninvasive analysis of ventricular tachycardia and early VF in patients with Brugada syndrome and ischemic cardiomyopathy shows a predictable sequence in the frequency-phase domain, consistent with anatomic location of the arrhythmogenic substrate.

8 March 2011 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
EGEsteban González‐Torrecilla
Esteban González‐Torrecilla
JAJesús Almendral
Jesús Almendral
FGF.Javier Garcia-Fernandez
F.Javier Garcia-Fernandez
MAMiguel A. Arias
Miguel A. Arias
AAAngel Arenal
Angel Arenal
FFFrancisco Fernández‐Avilés
Francisco Fernández‐Avilés